One of the major goals of the MedSolve technology is to achieve better glycemic control for a larger segment of the diabetic population. The Company is particularly interested in reducing the horrific complications of diabetes so that we can achieve a better quality of life for the millions of people who suffer from it.

As most of the general public has come to understand, it is economically better for insurance companies, and for the US government to provide early medical intervention for diseases such as diabetes, rather than allow the disease to progress.

By providing individuals a voice, and assistance in obtaining early treatment, we aim to help lower the cost of medical care in our region. It is our desire to serve as a model, one that can be cloned so that that these goals can ultimately be achieved nationwide.